Genome Sequencing Company Plans to Develop Liquid Biopsy for Cancer Detection
As many companies are trying to develop liquid biopsy for diagnosing and preventing cancer development, the San Diego-based genome sequencing company Illumina has also joined this group.
As many companies are trying to develop liquid biopsy for diagnosing and preventing cancer development, the San Diego-based genome sequencing company Illumina has also joined this group.
Post a Comment
Thanks for reading my blog.
Note: only a member of this blog may post a comment.